↓ Skip to main content

Immunotherapy resistance: the answers lie ahead – not in front – of us

Overview of attention for article published in Journal for Immunotherapy of Cancer, February 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (73rd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
11 tweeters

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
41 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Immunotherapy resistance: the answers lie ahead – not in front – of us
Published in
Journal for Immunotherapy of Cancer, February 2017
DOI 10.1186/s40425-017-0212-y
Pubmed ID
Authors

Miles C. Andrews, Jennifer A. Wargo

Abstract

Mechanisms of innate and adaptive resistance to checkpoint blockade immunotherapy are under intense investigation with a view to broadening the therapeutic potential of this form of treatment. In a recent manuscript by Zaretsky and colleagues, mutational events were identified that effectively crippled ongoing immunotherapy responses in patients treated with anti-PD-1 therapy. These results are discussed in the light of other recent and ongoing research efforts exploring both mutational and non-mutational resistance mechanisms, highlighting the critical translational importance of longitudinal tumor sampling.

Twitter Demographics

The data shown below were collected from the profiles of 11 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 41 100%

Demographic breakdown

Readers by professional status Count As %
Other 8 20%
Researcher 6 15%
Student > Bachelor 6 15%
Lecturer 4 10%
Student > Master 4 10%
Other 9 22%
Unknown 4 10%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 17 41%
Medicine and Dentistry 6 15%
Agricultural and Biological Sciences 5 12%
Pharmacology, Toxicology and Pharmaceutical Science 2 5%
Immunology and Microbiology 1 2%
Other 2 5%
Unknown 8 20%

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 March 2017.
All research outputs
#2,292,070
of 11,310,974 outputs
Outputs from Journal for Immunotherapy of Cancer
#154
of 456 outputs
Outputs of similar age
#68,020
of 259,332 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#14
of 28 outputs
Altmetric has tracked 11,310,974 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 456 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.8. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 259,332 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.